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Abstract: Recently, synthetic molecular nanomachines (MNMs) that rotate unidirectionally in 
response to UV light excitation have been used to produce nanomechanical action on live cells 
to kill them through the drilling of holes in their cell membranes. In the work here, visible light-
absorbing MNMs are designed and synthesized to enable nanomechanical activation by 405 nm 
light, thereby using a wavelength of light that is less phototoxic than the previously employed 
UV wavelengths. Visible-light absorbing MNMs that kill pancreatic cancer cells upon response 
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to light activation are demonstrated. Evidence is presented to support the conclusion that MNMs 
do not kill cancer cells by the photothermal effect when used at low optical density. In addition, 
MNMs suppress the formation of reactive oxygen species, leaving nanomechanical action as 
the most plausible working mechanism for cell killing under the experimental conditions. 
 
More methods of efficient cell killing would widen the field of available modalities for 
treatment of chemo-, radiation- and immuno-therapy-resistant cancers.[1],[2–5] Molecular motors 
and switches that change their conformation in a controllable manner in response to an external 
stimulus, such as light, have been demonstrated for molecular mechanical therapeutics.[6–10] 
Molecular mechanical therapeutics is promising because a cancer cell is unlikely to develop a 
defense mechanism against mechanical action. This therapeutic strategy, however, needs 
further development for clinical translation. 
We previously showed that by using molecular machines (MNMs) with 355-365 nm 
light activation and motors with unidirectional rotation rates of 2-3 MHz,[11] the MNMs drilled 
through cell membranes causing rapid blebbing and necrosis in various types of cancer cell 
lines.[1] In this first generation of cell-killing MNMs, the phototoxicity of UV-light toward 
untargeted cells is a concern due to the potentially high level of UV-induced reactive oxygen 
species (ROS) and reactive nitrogen species (RNS). In order to address this secondary UV-
induced damage, here we demonstrate a series of second generation, safer visible-light actuated 
MNMs. In our former work, we studied the treatment of single cancer cells using confocal 
microscopy. Here we treated colonies of KPC pancreatic cancer cells using MNMs, showing 
that cancer cells died upon 395-405 nm light emitting diode (LED) activation of the MNMs. 
Our results support the conclusion that MNMs work through molecular mechanical actions 
because the photothermal effects were minimized. In addition, we verified that MNMs do not 
enhance but rather quench ROS. 
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MNMs were designed and synthesized to absorb in the visible wavelengths of the 
spectrum and based upon the former work of Feringa and his group[12] (Figure 1, Supporting 
Figure S1, and Scheme S1-S4). Wavelengths of absorption are preferred outside the UV region 
to reduce the phototoxicity. While near infra-red (NIR) is attractive for higher penetration depth 
in biological tissue, the energies are too low to be useful for the MNM-induced membrane 
penetration. We recently used 2-photon NIR excitation of UV-activated MNM, but at the 
requisite high fluxes, penetration is still limited.[13] Now we have tuned the λmax of absorption 
to ~ 405 nm for MNM 7 by introducing an amine electrodonating substituent into the conjugated 
core of the fast motor where the rotation rate is calculated to be in the MHz region (See 
Supporting Information for comprehensive discussion on the estimation of rotation rates).[12] 
Likewise, by introducing the methoxy electrodonating group in MNMs 5, 6, and 8, the λmax was 
tuned to 370 nm with sufficient absorption at ~ 400 nm (Figure S1). MNMs 1 and 3 have a λmax 
of 401 nm but a slow rotating motor of 10-3 Hz. MNMs 2 and 4 have a medium speed rotating 
motor (102 Hz) with a λmax of 393 nm. All of the motors used in this study absorb 405 nm visible 
light (Supporting Figure S1 and Table S1). The side chains (hydroxyl or di(ethylene glycol)) 
attached to the core of the motor do not modify the λmax of the photoexcitation peak that 
typically is in the range of 370-405 nm for the MNMs in this study.  
MNMs were applied to the LSL-KrasG12D/+; LSL-Trp53R172H/+; Pdx-1-Cre cells (KPC), a 
genetically engineered mouse model of pancreatic ductal adenocarcinoma that recapitulates the 
biology of human pancreatic cancer.[14] Cell death on KPC cells is caused by visible-light 
activated MNMs (Figure 2). The cell death is quantified by the fluorescence intensity of 
propidium iodide (PI) intercalated into DNA or RNA in cells upon disruption of the cell 
membrane. PI only fluoresces upon cellular internalization and intercalation; it does not 
fluoresce in the cell culture medium alone. Light treatment (405 nm light for 15 min) alone does 
not kill the KPC cells during the imaging time frame of 25 min (15 min of 405 nm light 
activation followed by 10 min observation without light (this means the sample is maintained 
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in the dark). The slow rotating MNM 1 causes some minor cell death starting at 20 min (15 min 
of light treatment followed by 5 min observation without light). The medium rotating MNM 2 
causes cell death starting at 15 min during the light treatment. In contrast, the fast rotating MNM 
5 causes cell death starting ~ 5 min during the light activation. More importantly, MNM 7 
caused cell death faster than MNM 5 because the λmax of 7 is centered at 405 nm while the λmax 
of 5 is centered at 371 nm. Overall, it is observed that the visible light-activated motors kill 
cells in the order 7 > 5 > 2 > 1, which correlates with the respective rotation rate of 106 s-1 (7 
and 5) > 102 s-1 (2) > 10-3 s-1 (1).          
In addition to the onset time at which the cells start manifesting staining by PI, a peak 
in the fluorescence intensity in cells treated with 5 and 7 was observed usually at ~ 17.5 min. 
This peak is more evident when the individual data (not averaged) are analyzed as observed in 
Supporting Figure S2-S4. The decrease in the fluorescence intensity with time is due to the 
necrosis-induced blebbing and explosion-like ejection of PI-intercalated DNA or RNA into the 
medium which then quickly lessens in intensity due to dilution.  
The cellular accumulation and clearance of MNM 7 in KPC cells is tracked by its 
fluorescence (emission spectrum in Figure S5). MNM 7 is imaged using filters, λex = 405 nm 
and λem = 470 nm, conveniently available in most fluorescent microscopes, and applying a short 
time of excitation enough for imaging but not sufficient to activate the killing action of the 
MNM. The accumulation of 7 reaches saturation in the KPC cells at 1-1.5 h of incubation at 37 
°C when used at 8 µM in 0.1 % DMSO (Figure 3A and Figure S6). After 1-1.5 h, the KPC 
cells start clearing 7 as suggested by the decrease of the fluorescence intensity over time (Figure 
S6). The clearance of 7 from the KPC cancer cells is accelerated by replacing the media as 
observed by the plot of the black dots in Figure 3A.  
A 5 h clearance process removes most of 7 from the cytoplasm of KPC cells. This 5 h 
clearance involves of replacing the media 3 times at 1.5 h after the loading period, followed by 
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1 h incubation and replacing media 3 times, then 4 h incubation and replacing the media 3 times 
at 5 min before the imaging.  
The 22 h clearance process removes almost all of the 7 from the cytoplasm of KPC cells 
(Figure 3B). Fluorescence images in Figure 3B support the conclusion that the fluorescence 
decays over time. This 22 h clearance process consists of replacing the media 3 times at 1.5 h 
after the loading period, followed by 1 h incubation and replacing media 3 times, then 4 h 
incubation and replacing the media 3 times, then 17 h incubation and replacing the media 3 
times 5 min before the imaging. 
To confirm that 7 is cleared over time, 405 nm light treatment is applied to the KPC 
cells at the different time points of clearance (Figure 3C). It is observed that as more 7 is cleared 
from the cell cytoplasm, the less cell death is observed when 7 and 405 nm light treatment is 
applied. Interestingly, there is no effect on the cell death upon light treatment when 7 was 
completely cleared after the 22 h clearance process was applied. 
An off-the-shelf LED light is sufficient to activate the MNMs and caused cell death in 
KPC cells. The purpose of using an LED light is to demonstrate the versatility in activating the 
MNMs. We observed consistency in the results regardless of the activation method. Cell death 
was caused by MNMs upon treatment with an LED light at 395 nm for 15 min using a light 
power of 160 mWcm-2 (Figure 4). MNMs 1, 2 and 5 are added at 8 µM and 0.1 % DMSO in 
the final cell media in order to avoid unwanted cell membrane permeabilization; DMSO being 
required for solubility of the organic MNMs. The free MNMs are washed 3x with fresh media 
before the light treatment. It was observed that light treatment alone does not kill the cancer 
cells within the imaging time frame from 2.5-20 min after the light treatment (Figure 4A). For 
clarity in the interpretation of the results, the imaging time point in the x-axis in Figure 4A 
starts counting at zero when the 15 min light treatment is completed. However, time zero is not 
recorded because it takes 3 min to set up the cell culture dish in the microscope and start 
imaging. The MNMs alone do not kill cancer cells (Figure 4B and Supporting Figure S7). 
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Light-activated 2 (medium rotation rate 102 s-1) and 5 (fast rotation rate 106 s-1) cause cell death 
to the relative extents expected. In contrast, light activated slow MNM 1 initiates little cell 
death. The relative capacity of MNMs to kill cancer cells is 5 > 2 > 1. This relative ability to 
kill cancer cells is qualitatively observed in the fluorescence images showing the internalized 
PI in KPC cells 5 min after the light treatment was completed. 
To investigate photothermal effects, the temperature of the media was measured under 
the light treatment conditions using an LED light (395 nm light at 160 mWcm-2 for 15 min) 
with or without MNM present (Supporting Figure S8). The results show that the light treatment 
alone increased the temperature of the media by only ~ 0.5 °C. The presence of 8 µM MNM 1, 
the MNM with highest absorption cross section at 395 nm in this study, under the light treatment 
increased the temperature only 0.5 °C above the light treatment alone. This suggest that light 
treatments and MNMs as applied in this study cause minimal photothermal driven effects. The 
slow rotating MNM 1 and the medium rotating MNM 2 minimally increased the temperature 
of the media under the light treatment due to their larger absorption cross-section than MNM 5 
(Supporting Figure S1). However, MNM 1 and 2 caused less cell death than MNM 5 and MNM 
7 (Figure 2 and Figure 4), confirming that the photothermal effect is not the dominating 
mechanism for cell death under the conditions in this study. To further support this conclusion, 
the MNM were compared at equal optical density (OD) = 0.08 under activation using LED light 
at 395 nm (Figure S9) or using light at 405 nm (Figure S10). If the mechanism of action were 
by a photothermal effect, the machines 1, 2, and 5 should kill the cancer cells similarly 
regardless of the MNM rotation rate when compared at equal OD of 0.08. However, the results 
at equal OD show that MNMs kill cells in the order 5 > 2 > 1, further confirming that 
photothermal is not the driving mechanism.      
The PEGylated MNMs 3, 4, 6, and 8 were applied to KPC cells and activated with 405 
nm light or 395 nm LED light (Supporting Figure S11-S13). The PEGylated MNM 8 caused 
more cell death than MNMs 3 and 4 due to its faster rotation rate (Figure S11). The MNM 6, 
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which is homologous in the core structure to non-PEGylated 5 and di-PEGylated 8 but different 
due to the single PEG arm, showed similar effect on the cell death to 5 as expected since both 
MNMs have the same rotation rate, therefore similar mechanical action is produced to damage 
cellular organelles. The MNM 4 killed the KPC cells faster than 3 as expected since 4 has higher 
rotation rate than 3.          
To confirm that ROS formation is not the mechanism of action of MNM, the ROS 
production during the 405 nm light treatment under the inverted fluorescent microscope was 
measured using CellRoxTM green reagent. CellRoxTM green dye is weakly fluorescent in its 
reduced form but exhibits bright green fluorescence upon oxidation by ROS and subsequent 
binding to DNA with absorption/emission maxima at 485/520 nm.[15] The 405 nm light 
treatment alone produces ROS in the KPC cells (Figure 5). The photosensitizer chlorin e6 
enhances ROS production upon 405 nm light excitation.[16] In contrast, the ROS inhibitor N-
acetyl-L-cysteine (NALC) partially quenches ROS.[17] Interestingly, the MNMs 2, 5, and 7 
under 405 nm light treatment suppress the production of ROS relative to the light treatment 
alone. There has been extensive investigation of the UV-induced addition of singlet oxygen 
(1O2) across carbon-carbon double bonds for the photooxygenation of perylene structures.
[18] 
This supports the observation that the twisted double bond present in the MNM structures is 
highly reactive to oxygen radicals, acting as a ROS quencher. MNM 5 and 7 have slightly higher 
ROS generation than does MNM 2 because the mechanical action by the faster MNMs likely 
increases ROS generation. But the bulk of ROS is quenched by the MNMs, regardless of their 
rotational spinning rates.     
To conclude, we demonstrated that visible-light absorbing MNMs kill pancreatic cancer 
cells upon 405 nm light excitation. The visible-light activated MNMs work under less 
phototoxic conditions than our previously reported UV-light activated MNMs. We showed that 
MNMs were cleared from the cellular cytoplasm over time, suggesting their low toxicity as 
observed formerly.1,13 Our results support the conclusion that MNMs do not kill cancer cells by 
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the photothermal effect under the tested conditions in this study. In addition, MNMs suppress 
the formation of ROS; therefore, ROS formation is not responsible for the cell death caused by 
MNMs. The evidence supports the conclusion that MNMs kill by mechanical action when 
excited by visible light. The limitation of this approach is the difficulty to treat deep seated 
tumors due to the poor penetration depth of blue light in biological tissue. However, this 
approach can be further developed for light accessible cancers such as squamous or basal cells 
carcinomas and other pathologic conditions in the skin.  
 
Experimental Section 
Experimental details can be found in the supporting information.  
Supporting Information 
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Figure 1. Visible-light-activated MNMs. MNMs 1 and 3 are synthesized with a slow motor 
in the core (10-3 Hz rotation rate) and varied side chains. MNMs 2 and 4 are synthesized with 
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motors having a medium rotation rate (102 Hz rotation rate) and varied side chains. MNMs 5 - 
8 are synthesized with a fast motor (106 Hz rotation rate) and varied side chains. 
 
Figure 2. Cell death caused by MNMs under microscope excitation at 405 nm. A) Cell 
death is quantified by the fluorescence intensity of PI intercalation into DNA or RNA in the 
KPC cells upon cell membrane disruption. Imaging time points start when the 405 nm light is 
turned on. B) Fluorescence images of PI intercalation into DNA or RNA in KPC cells (for 1, 2, 
5 fluorescence pixels are rendered in the range of 10-60 intensity to improve visualization while 
7 is rendered at 0-250 pixel intensity). Samples are treated for 15 min with light using the 40x 
microscope objective and 405/60 nm light filter at light power of 25 mW (estimated light flux 
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of 500 mWcm-2). MNMs concentration is 8 µM and 0.1 % DMSO and cells are incubated 1.5 
h at 37 °C. Then, free MNMs in the media are washed 3x with fresh media before the light 
treatment. PI imaging conditions include an excitation band pass filter at 546/12 nm, dichroic 
mirror at 565 nm, and emission band pass filter at 600/40 nm. In all studies in this work, 0.1 % 
DMSO was used as a cosolvent to ensure MNM solubility. The DMSO at this concentration 
has no observed effect on cell behavior.[1] The bars represent standard deviation of the 
fluorescence intensity (~ 55 cells per field of view) across multiple experiment repetitions (n = 
3). The scale bar is the same for all images = 100 µm. 
 
Figure 3. Loading and clearance of MNM 7 and its effect on cell death under microscope 
excitation at 405 nm. A) Fluorescence intensity of 7 in KPC cells. Loading (blue dots) of 7 at 
8 μM in the KPC cells at 0.25 h, 0.5 h, 1 h and 1.5 h after incubation and washing 3x with fresh 
media before imaging, and clearance (black dots) upon washing 3x with fresh media at 1.5 h 
and continued incubation for 1 h, 5 h and 22 h.  B) Fluorescence images of 7 loaded/cleared in 
the KPC cells. Imaging: excitation BP 405/60nm, dichromatic mirror 455 nm, and emission BP 
470/40 nm. Scale bar is the same for all images = 30 µm. C) Cell death quantified by the 
internalized PI fluorescence intensity of the KPC pancreatic cancer cells treated with 7 at 8 µM 
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(1.5 h incubation at 37 °C) and 405 nm light. The PI concentration in the media was 1.5 µM in 
this and all other cell death experiments. The x-axis is the excitation time and post-excitation 
time. Light was applied after designated wash and clearance cycles were completed. Light 
treatments were for 15 min with the 40x microscope objective and 405/60 nm light filter at light 
power of 25 mW (estimated light flux of 500 mWcm-2). PI imaging conditions used an 
excitation band pass filter at 546/12 nm, dichroic mirror at 565 nm, and emission band pass 
filter at 600/40 nm. “No wash”: Cells are incubated with 7 at 8 µM for 1.5 h at 37 °C and then 
treated with light. “Wash 3x”: Cells are incubated with 7 at 8 µM for 1.5 h at 37 °C, then 
washed 3x with fresh media, and then treated with light. “Wash 3x + 1 h clearance + wash 
3x”: Cells are incubated with 7 at 8 µM for 1.5 h at 37 °C, then washed 3x with fresh media, 
then incubated 1 h, then washed 3x with media, and then treated with light. “Wash 3x + 22 h 
clearance + wash 3x”: Cells are incubated with 7 at 8 µM for 1.5 h at 37 °C, then washed 3x 
with fresh media, then incubated 1 h and washed 3x, then incubated 5 h and washed 3x, then 
incubated 17 h and washed 3x, and then treated with light. The bars represent standard deviation 
of the fluorescence intensity (~ 55 cells per field of view) across multiple experiment repetitions 
(n = 3).  




Figure 4. Cell death caused by MNM after LED 395 nm light excitation for 15 min. A) 
Cell death quantified by the fluorescence intensity of PI intercalation into DNA or RNA in the 
KPC cells. Imaging time points start 3 min after the light treatment is turned off and the 
fluorescence was not recorded during the 15 min of light treatment. The fluorescence intensity 
before the light treatment is reported in the Supporting Information Figure S7. B) Fluorescence 
images of PI intercalation into DNA or RNA in KPC cells at 5 min after the light treatment and 
control samples without light treatment. MNMs 1, 2 and 5 are added at 8 µM and 0.1% DMSO. 
Then, after incubation at 37 °C for 1.5 h, unbound MNMs are partially removed by washing 3x 
with fresh media before the light treatment. Samples are treated for 15 min with an LED lamp 
at 395 nm and an average light flux of 160 mWcm-2, placing the bottom of the LED head 1 cm 
above the culture dish in all the treatments. Imaging filters for PI involve excitation band pass 
filter at 546/12 nm, dichroic mirror at 565 nm, and emission band pass filter at 600/40 nm. The 
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bars represent standard deviation of the fluorescence intensity (~ 300 cells per field of view) 
across multiple experiment repetitions (n = 4). Scale bar is the same for all images = 150 µm. 
 
Figure 5. ROS quenching by MNMs. A) CellRoxTM signal (ROS production) in KPC cells 
under 405 nm light excitation. Long exposure to 405 nm light causes some photobleaching of 
CellRoxTM green reagent. B) Fluorescence imaging of CellRoxTM (green) in KPC cells at 5 min 
of treatment with 405 nm light.  Samples are illuminated for 15 min with 405 nm light under 
the fluorescence microscope at light power of 25 mW (estimated light flux of 500 mWcm-2). 
After the light treatment, the CellRoxTM signal (indicative  of CellRoxTM oxidation by ROS) is 
quantified at specific time points using excitation band pass filter at 480/40 nm, dichroic mirror 
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at 505 nm, and emission band pass filter at 527/30 nm. MNMs 1, 2 and 5 are added at 8 µM, 
chlorine e6 and NALC were added at 8 µM, all samples contained 0.1% DMSO. The bars 
represent standard deviation of the fluorescence intensity (~ 55 cells per field of view) across 
multiple experiment repetitions (n = 3). Scale bar is the same for all images = 100 µm.    
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